LIVESTRONG Cancer Institutes

Aug 28, 2024 | jamanetwork.com | Ayisha N. Mahama |Courtney Haller |Adewole S. Adamson |LIVESTRONG Cancer Institutes

Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?—Reply Experience and Fear of Cancer Recurrence Among Survivors of Localized Melanoma Ayisha N. Mahama, MD, MPH; Courtney N. Haller, MD; Jocelyn Labrada, BA; Christie I. Idiong, MS; Alex B. Haynes, MD, MPH; Elizabeth A. Jacobs, MD,, MAPP; Joel Tsevat, MD, MPH; Michael P. Pignone, MD, MPH; Adewole S.

May 14, 2023 | frontiersin.org | LIVESTRONG Cancer Institutes

Keywords: Digital Twin, risk-aware clinical decision-making, personalized tumor forecasts, uncertainty quantification, adaptive radiotherapy, mathematical oncology, brain cancer Copyright: © 2023 Chaudhuri, Pash, Hormuth, II, Lorenzo, Kapteyn, Wu, Lima, Yankeelov and Willcox. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).

Mar 20, 2023 | academic.oup.com | LIVESTRONG Cancer Institutes |Jordan Wright

Individuals with long-standing (1, 2) and recently diagnosed (3, 4) type 1 diabetes (T1D) have smaller pancreata than age-matched nondiabetic individuals (2, 4). Histologic studies of the pancreas of deceased donors with long-standing T1D suggest that these changes are due to loss of acinar cell number (5, 6). It is not known whether the changes in pancreas size represent an acute or ongoing process that continues in long-standing T1D.